Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Essen Biotech
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Shenzhen Second People's Hospital
Barbara Ann Karmanos Cancer Institute
University of Kentucky
Northwestern University